Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
This collects basic information about your health history, current medications, and goals
Understanding the Connection Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for the treatment of type 2 diabetes
Saxenda and Victoza have the same active ingredient, liraglutide, and should not be used together or with other GLP-1 receptor agonist medicines It is not known if Saxenda is safe and effective when taken with other prescription, over-the-counter medicines, or herbal weight-loss products It is not known if Saxenda is safe and effective in children under 12 years of age It is not known if Saxenda is safe and effective in children aged 12 to 17 years with type 2 diabetes Do not share your Saxenda pen with others even if the needle has been changed
(5.10) Adverse Reactions/Side Effects The most common adverse reactions, reported in 5% of patients treated with MOUNJARO are nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, and abdominal pain
For type 2 diabetes, options include Ozempic (semaglutide), Rybelsus (oral semaglutide), Trulicity (dulaglutide), Victoza (liraglutide), Bydureon (exenatide), and Lyxumia (lixisenatide)
US$ 20.52
US$ 25.62
US$ 20.40
